Autonomix Medical, Inc.
NASDAQTotal Valuation
Autonomix Medical, Inc. carries a market capitalization of 3.49M, placing it among publicly traded companies globally. Its enterprise value stands at -4.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.49M |
| Enterprise Value | -4.73M |
Share Statistics
Autonomix Medical, Inc. currently has 543,302.00 shares outstanding.
| Shares Outstanding | 543,302.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.03 |
| P/TBV Ratio | 0.39 |
| P/FCF Ratio | -0.19 |
| P/OCF Ratio | -0.18 |
Financial Position
Autonomix Medical, Inc. maintains a current ratio of 4.45, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.45 |
| Quick Ratio | 4.11 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -192.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Autonomix Medical, Inc.'s stock has declined approximately -78.28436% over the past 52 weeks. The 50-day moving average sits at 7.65, while the 200-day moving average is 12.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | -78.28436% |
| 50-Day Moving Average | 7.65 |
| 200-Day Moving Average | 12.70 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -17.02M, while operating income came in at -17.03M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -17.03M |
| Pretax Income | -16.71M |
| Net Income | -16.71M |
| EBITDA | -17.02M |
| EBIT | -17.03M |
| Earnings Per Share (EPS) | -60.27 |
Balance Sheet
Total book value stands at -67.08M, with working capital of 5.88M providing operational flexibility.
| Cash & Cash Equivalents | 7.00M |
| Total Debt | N/A |
| Net Debt | -7.00M |
| Equity (Book Value) | -67.08M |
| Book Value Per Share | -241.88 |
| Working Capital | 5.88M |
Cash Flow
Autonomix Medical, Inc. produced -12.28M in operating cash flow over the past twelve months. After subtracting -10,000.00 in capital expenditures, free cash flow totaled -12.29M - equivalent to -44.32 per share.
| Operating Cash Flow | -12.28M |
| Capital Expenditures | -10,000.00 |
| Free Cash Flow | -12.29M |
| FCF Per Share | -44.32 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -447.29 |
| FCF Yield | -540.27 |
Stock Splits
Autonomix Medical, Inc.'s most recent stock split took place on June 24, 2026 with a 21:1 split ratio.
| Last Split Date | 6/24/2026 |
| Split Ratio | 21:1 |
Scores
Autonomix Medical, Inc. posts an Altman Z-Score of -18.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -18.03 |